Temporally resolved early bone morphogenetic protein-driven transcriptional cascade during human amnion specification

Area of Science:

• Developmental Biology
• Stem Cell Biology
• Reproductive Biology

Background:

• Amniogenesis is vital for healthy pregnancy, initiated by bone morphogenetic protein (BMP) signaling in pluripotent epiblast cells.
• Downstream BMP-dependent transcriptional networks governing amniogenesis are not fully understood.
• A lack of robust models hinders mechanistic studies of amniogenesis.

Purpose of the Study:

• To develop an improved, controllable human pluripotent stem cell model for studying amniogenesis.
• To identify and characterize the BMP-dependent transcriptional cascade in early amnion specification.
• To uncover key factors regulating amniogenesis progression.

Main Methods:

• Developed a human pluripotent stem cell platform with controlled, synchronous BMP signaling activation.
• Performed time-course transcriptomic analyses to map gene expression dynamics.
• Validated marker expression in early post-implantation macaque embryos.
• Investigated the functional role of identified factors, including TFAP2A.

Main Results:

• Achieved uniform amniogenesis within 48 hours of BMP activation in the stem cell model.
• Identified a novel BMP-dependent amniotic transcriptional cascade with five distinct specification stages.
• Validated selected markers in non-human primate embryos.
• Demonstrated that TFAP2A is a critical regulator of amniogenesis progression downstream of BMP signaling.

Conclusions:

• The study presents a robust stem cell model for investigating amniogenesis.
• A detailed transcriptomic resource for amniogenesis states was established.
• TFAP2A plays a crucial intermediate role in regulating amnion fate specification during early human development.